早期宫颈癌女性前哨淋巴结活检的敏感性和阴性预测值
该回顾性研究纳入1997年8月至2015年10月接受前哨淋巴结(SLN)定位及完整盆腔淋巴结清扫的早期宫颈癌女性188例,35例(19%)有淋巴结转移。SLN检出率90%,双侧检出率62%;仅1例假阴性,敏感性96.4%(95%CI 79.8%-99.8%),阴性预测值99.3%(95%CI 95.6%-100%),假阴性率3.6%。作者认为应将早期宫颈癌的标准治疗改为仅行SLN活检。
要点
- 188例早期宫颈癌中,35例(19%)存在淋巴结转移。
- SLN检出率90%,双侧SLN检出率62%,多数SLN位于盆腔(83%)。
- 敏感性96.4%(95%CI 79.8%-99.8%),阴性预测值99.3%(95%CI 95.6%-100%),假阴性率3.6%。
核心结论
- 在早期宫颈癌女性中,SLN活检具有很高的敏感性和阴性预测值。
- 作者认为应将早期宫颈癌女性的标准治疗改为仅行SLN活检。
研究设计与样本
- 回顾性研究,纳入1997年8月至2015年10月接受SLN定位后行完整盆腔淋巴结清扫作为初始手术管理的早期宫颈癌女性188例。
- 纳入所有手术入路,淋巴定位使用蓝染剂、锝-99m硫胶体(Tc-99)和/或吲哚菁绿(ICG)。
主要发现
- 188例中35例(19%)有淋巴结转移。
- 170例(90%)至少检出1枚SLN,117例(62%)检出双侧SLN,83%的SLN位于盆腔。
- 不同定位剂、手术入路、既往有无宫颈锥切、肿瘤<2cm与≥2cm之间的检出率无差异。
- 体重指数(BMI)>30kg/m2的女性双侧SLN检出率显著低于BMI较低的女性(p=0.03)。
- 前哨淋巴结转移78%的病例经H&E染色检出,22%的病例需超分期/免疫组化检出。
关键数值与推荐
- 仅1例假阴性,敏感性96.4%(95%CI 79.8%-99.8%),阴性预测值99.3%(95%CI 95.6%-100%)。
- 假阴性率为3.6%。
临床怎么用
- 作者认为应将早期宫颈癌女性的标准治疗改为仅行SLN活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The role of sentinel lymph node (SLN) biopsy alone for staging of early-stage cervical cancer remains controversial. We aimed to determine the validity of this technique in women with early-stage cervical cancer. METHODS: We retrospectively reviewed women with early-stage cervical cancer who underwent SLN mapping followed by complete pelvic lymphadenectomy as part of initial surgical management from August 1997 through October 2015. All modes of surgical approach were included. Lymphatic mapping was performed using blue dye, technetium-99m sulfur colloid (Tc-99), and/or indocyanine green (ICG). We determined SLN detection rates, sensitivity and negative predictive value. RESULTS: One hundred eighty-eight patients were included, and 35 (19%) had lymph node metastases. At least one SLN was identified in 170 patients (90%), and bilateral SLNs were identified in 117 patients (62%). The majority of SLNs (83%) were found in the pelvis. There was no difference in detection rates between mapping agents, surgical approach, patients with and without prior conization or between patients with tumors <2cm and ≥2cm. The detection rate for bilateral SLNs was significantly lower in women with body mass index (BMI)>30kg/m2 than in women with lower BMI (p=0.03). Metastatic disease in sentinel nodes was detected by H&E staining in 78% of cases and required ultrastaging/immunohistochemistry in 22% of cases. Only one patient had a false-negative result, yielding a sensitivity of 96.4% (95% CI 79.8%-99.8%) and negative predictive value of 99.3% (95% CI 95.6%-100%). The false-negative rate was 3.6%. CONCLUSIONS: In these women with early-stage cervical cancer, SLN biopsy had very high sensitivity and negative predictive value. We believe it is time to change the standard of care for women with early-stage cervical cancer to SLN biopsy only.
引用
- Salvo G, Ramirez PT, Levenback CF, et al. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol. 2017. PMID: 28188015. doi:10.1016/j.ygyno.2017.02.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。